Healthcare Products Quarterly
Q3 2020 UPDATE
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.
Headline Transactions
ACADIA PHARMACEUTICALS ACQUIRES CERSCI THERAPEUTICS FOR $52.5M
August 25, 2020: ACADIA Pharmaceuticals is adding a novel pain portfolio to its pipeline through the acquisition of Texas-based CerSci Therapeutics for $52.5 million. The acquisition is expected to bolster ACADIA’s clinical pipeline to include non-opioid pain therapies that have potential non-addictive properties and reduced side effects typically seen with current opioid treatments.
ROYAL PHILLIPS SET TO ACQUIRE INTACT VASCULAR FOR $275M
August 26, 2020: Royal Philips, a global leader in health technology, is set to acquire Intact Vascular, Inc., a U.S.-based developer of medical devices for minimally-invasive peripheral vascular procedures. Intact Vascular will enhance Philips’ image-guided therapy portfolio, combining Philips’ interventional imaging platform and diagnostic and therapeutic devices with Intact Vascular’sunique, specialized implantable device to optimize the treatment of patients with Peripheral Artery Disease (PAD). The deal is worth approximately $275 million.
WARBY PARKER CLOSES COMBINED $245M IN TWO ROUNDS
September 2, 2020: CryoLife, Inc. ("CryoLife"; NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced that it has acquired AscyrusMedical LLC (Ascyrus) in a transaction worth $200 million. Ascyrusis a Florida-based, privately-held developer of the AscyrusMedical Dissection Stent (AMDS™), the world's first aortic arch remodeling device used for the treatment of acute Type A aortic dissections. The addition of the AMDS to CryoLife'sproduct portfolio further strengthens the Company's position as a leader in the growing aortic repair market.
CRYOLIFE ACQUIRES ASCYRUS MEDICAL FOR $200M
August 27, 2020: JAND Inc., which does business as WarbyParker, closed a combined $245 million in two funding rounds this year, raising the value of the optical e-commerce company to $3 billion, TechCrunch reported, citing a source familiar with its finances. A $125 million series F round in the second quarter was led by Durable Capital Partners LP and a $120 million series G round in the third quarter was led by D1 Capital Partners LP. Investors in the latest rounds included T. Rowe Price Group Inc. and Baillie Gifford & Co.
PUBLIC FINANCIAL METRICS
EBITDA Multiples
One-Year Stock Performance & Revenue Growth (9-30-2020)
LTM Gross & EBITDA Margin
LTM Debt/EBITDA
YoY, LTM and Previous 3-year Performance Benchmarks
